1AI for cardiometabolic health:novel strategies for prevention and careCHEN Wen-jia, SHI Jing, LI Yue, FU YuSYMPOSIUM·CARDIOMETABOLIC DISEASES893-8982Diet-Gut microbiota axis:a new perspective on the intervention of cardiovascular metabolic diseasesWU Yuan-jing, BAI Ming, WU YueSYMPOSIUM·CARDIOMETABOLIC DISEASES899-9033Management of the factors of metabolic abnormalities in panvascular diseaseQIAN Ju-yingSYMPOSIUM·CARDIOMETABOLIC DISEASES904-9094Risk screening and interventional management of cardiometabolic diseases related to visceral adiposityLIU Jing, KONG Xiang-qingSYMPOSIUM·CARDIOMETABOLIC DISEASES910-9125Current status and prospects of clinical diagnosis and management of salt sensitive hypertensionMA Zhi-yiSYMPOSIUM·CARDIOMETABOLIC DISEASES913-916,9266Exercise for cardiometabolic diseases:multi-target and comprehensive pathway benefitsZHOU Le-qun, SHEN Tao, TANG Yi-daSYMPOSIUM·CARDIOMETABOLIC DISEASES917-9207Emerging insights into the interplay between dyslipidemia and cardiometabolic diseases:mechanisms and therapeutic strategiesMA Run-ze, QUAN Nan-huSYMPOSIUM·CARDIOMETABOLIC DISEASES921-9268Study on the correlation of serum monoamine oxidase and inflammatory markers with the severity of coronary artery lesionsZHAO Xiao-tong, CAO QianORIGINAL CONTRIBUTIONS952-9569Study on the correlation between ketosis episodes and risk of atherosclerosis in patients with newly-onset ketosis-prone type 2 diabetesZHU Hai-wei, LIANG Lin-lang, YU Hao, WANG Yu, LI Yu-jieORIGINAL CONTRIBUTIONS957-96110Clinical features and etiological analysis of 195 patients with pyogenic liver abscessJIN Chao, DONG Guo-zhen, LI Xiao-ting, LIU Hong-yu, SU Man, LI Ji-jiao, WEI Yan-chun, WANG Ke-shan, CAI Cai-lian, JIANG Jian-ning, SU Ming-huaORIGINAL CONTRIBUTIONS962-968